Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Data Steward Hyderabad (Office) India Operations CTS Marketing Oct 23, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 23, 2024
Associated Director – Senior Project Manager Prague Czech Republic Operations CTS Technology Transformation Oct 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Prague Czech Republic Operations CTS Technology Transformation Oct 23, 2024
Director - LDC Business and IT Controls(SAP GRC functional) Hyderabad (Office) India Operations CTS Technology Transformation Oct 23, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation Oct 23, 2024
Assoc. Director- Solutions Delivery (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation Oct 23, 2024
Business Data Migration Lead INSURGENTES Mexico Operations CTS BD&L & Strategic Planning Oct 23, 2024
Record to Report Sr. Specialist USA INSURGENTES Mexico Finance CTS Audit & Finance Oct 23, 2024
Associate Director(SAP SD S/4Hana) Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Director - Enterprise Architect, APD Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. Platform Analytics Architecture Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Senior Manager Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 22, 2024
Talent Acquisition Coordinator INSURGENTES Mexico People & Organization CTS Human Resources Oct 22, 2024
LDC - Data Business Workstream lead - Material Master Prague Czech Republic Operations CTS Technical Operations Oct 22, 2024
Analyst - Forecasting Hyderabad (Office) India Operations CTS Marketing Oct 22, 2024
Sr. Spec. Cloud Infrastructure Solution Delivery - Global Drug Development INSURGENTES Mexico Operations CTS Technology Transformation Oct 22, 2024
Time Services Expert – US & Canada INSURGENTES Mexico People & Organization CTS Human Resources Oct 22, 2024
Assoc Director - Service Management (ITIL , ITSM - Salesforce) Hyderabad (Office) India Operations CTS Technology Transformation Oct 15, 2024
External Workforce Management Process Specialist Prague Czech Republic People & Organization CTS Human Resources Oct 15, 2024
Novartis Operation Corporate Center (NOCC) Mexico City Head INSURGENTES Mexico Operations CTS Commercial & General Management Oct 15, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Oct 15, 2024
H2R Services Expert Moscow (City) Russian Fed. People & Organization CTS Human Resources Oct 15, 2024
External Workforce Management Process and Compliance Lead Prague Czech Republic People & Organization CTS Human Resources Oct 16, 2024
Manager, AI Operations Hyderabad (Office) India Operations CTS Marketing Oct 16, 2024
IT Program/ Project Manager Clinical Analytics Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 16, 2024
Human Capital Management | Global PMO (Temporary role 18 months) INSURGENTES Mexico People & Organization CTS Human Resources Oct 09, 2024
Assoc. Dir. DDIT ISC SecOps VulnSvcs Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Sr. Spec. DDIT IES O365 Sec. & Compl. Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Associate Director DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Lead Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
Senior Consultant Prague Czech Republic Operations CTS BD&L & Strategic Planning Oct 10, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Oct 18, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) India Operations CTS Technology Transformation Oct 18, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Information Technology Oct 18, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Buyer - Corporate Spend Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Buyer - Marketing Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Jun 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Jul 22, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only